Skyepharma
NDC Database

Skyepharma

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 4
  • Latest Marketing Date 2022-03-01
  • Data Source FDA
  • First Marketing Date 2022-03-01
Company Overview

Company

Skyepharma

Country

France

Social Profiles

LinkedIn
Company Snapshot

Skyepharma

55 Rue du Montmurier, 38070 Saint-Quentin-Fallavier

France

www.skyepharma.com/ info@skyepharma.com View on Map
NDC Records ( 4 records )
2022
01 Mar
Drug for Further Processing NDC: 13672-001

Nonproprietary Name

ZONISAMIDE

Dosage Form

CAPSULE

Strength

0.3333 kg/kg

Labeler

Skyepharma Production SAS

Marketing Category

DRUG FOR FURTHER PROCESSING

13672-001

Substance

ZONISAMIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
01 Mar
Drug for Further Processing NDC: 13672-002

Nonproprietary Name

ZONISAMIDE

Dosage Form

CAPSULE

Strength

0.3333 kg/kg

Labeler

Skyepharma Production SAS

Marketing Category

DRUG FOR FURTHER PROCESSING

13672-002

Substance

ZONISAMIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
01 Mar
Drug for Further Processing NDC: 13672-680

Nonproprietary Name

ZONISAMIDE

Dosage Form

CAPSULE

Strength

100 mg/kg

Labeler

SKYEPHARMA PRODUCTION SAS

Marketing Category

DRUG FOR FURTHER PROCESSING

13672-680

Substance

ZONISAMIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
01 Mar
Drug for Further Processing NDC: 13672-681

Nonproprietary Name

ZONISAMIDE

Dosage Form

CAPSULE

Strength

25 mg/kg

Labeler

SKYEPHARMA PRODUCTION SAS

Marketing Category

DRUG FOR FURTHER PROCESSING

13672-681

Substance

ZONISAMIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    5 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

13672-001

Nonproprietary Name

ZONISAMIDE

Labeler

Skyepharma Production SAS

Dosage Form

CAPSULE

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.